As of June 2026, according to BIO-TECHNE's current financial statements, the company's 12-month EPS is $0.71. For the year 2025, the company recorded an earnings per share (EPS) of $0.47, which marks a drop compared to its EPS of $1.07 in 2024. BIO-TECHNE's earnings per share for the quarterly report ending on Mar 31, 2026 reached $0.33.
The annual EPS for the year 2025 was $0.47, a drop of 56.1% from $1.07 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.33, showing a 135.7% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $0.71. For the year 2024, the yearly earnings per share was $1.07, marking a decrease of 40.9% from 2023.
BIO-TECHNE has registered an increase in EPS of 135.7% during the last 12 months (YoY, quarterly). In the last three years, TECH recorded an average annual EPS growth rate of -35.2%. BIO-TECHNE had an average annual EPS growth rate of -20.7% during the last 5 years. Across the last decade, TECH had an average annual EPS growth of -4.2%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| STEM Stem Inc | 0.45 | 115.6% | N/A | N/A |
| QGEN Qiagen NV | 19.88 | 415.8% | 1.8% | 3.9% |
| TMO Thermo Fisher Scientific Inc | 25.49 | 7.2% | 0% | 2% |
| DHR Danaher Corp | 34.2 | -4.9% | -19.7% | 0.4% |
| BDX Becton Dickinson & Co | 36.76 | -0.9% | -0.6% | 16.2% |
| GE General Electric Co | 43.6 | 35.8% | 447.4% | 12.1% |
| BIO Bio-Rad Laboratories Inc | 47.24 | 142.6% | N/A | -26.3% |
| TECH BIO-TECHNE Corp | 79.82 | -56.1% | -35.2% | -20.7% |
All data is based on quarterly TTM periods, unless otherwise specified.